login
login

Europe Daily Bulletin No. 13047

21 October 2022
Contents Publication in full By article 22 / 28
EU RESPONSE TO COVID-19 / Health
EMA recommends Spikevax vaccine adapted for BA.4 and BA.5 and opens door to vaccination of young children
Brussels, 20/10/2022 (Agence Europe)

The European Medicines Agency (EMA) issued several recommendations on Wednesday 19 October in favour of vaccines against Covid-19.

The EMA is recommending the authorisation of the bivalent Covid-19 vaccine (Spikevax) developed by the pharmaceutical company Moderna, adapted not only to fight the original SARS-CoV-2 strain, but also two of its sub-variants of concern: BA.4 and BA.5. This vaccine is intended for people over 12 years of age who have already completed a first vaccination...

Contents

EUROPEAN COUNCIL
Russian invasion of Ukraine
SECTORAL POLICIES
EUROPEAN PARLIAMENT PLENARY
ECONOMY - FINANCE - BUSINESS
EXTERNAL ACTION
EU RESPONSE TO COVID-19
COURT OF JUSTICE OF THE EU
NEWS BRIEFS